Advertisement

In-Vivo Models of Arrhythmias: a Canine Model of Sudden Cardiac Death

  • George E. Billman

Keywords

Heart Rate Variability Ventricular Fibrillation Susceptible Animal Left Circumflex Coronary Artery Great Cardiac Vein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Billman GE (1989) The effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation. J Pharmacol Exp Therap 248: 1334–1342Google Scholar
  2. Billman GE (1990) The effect of carbachol and cyclic GMP on susceptibility to ventricular fibrillation. FASEB J 4: 1668–1673PubMedGoogle Scholar
  3. Billman GE (1994) The role of the ATP-sensitive K+ channel in K+ accumulation and cardiac arrhythmias during myocardial ischemia. Cardiovasc Res 28: 762–769PubMedGoogle Scholar
  4. Billman GE (2002a) Aerobic exercise conditioning: a non-pharmacological antiarrhythmic intervention. J Appl Physiol 92: 446–454PubMedGoogle Scholar
  5. Billman GE (2002b) Animal Models of Lethal Arrhythmias. Drug Dev Res 55: 59–72CrossRefGoogle Scholar
  6. Billman GE, Hoskins RS (1988) Cocaine induced ventricular fibrillation: Protection afforded by the calcium channel antagonist verapamil. FASEB J 2: 2990–2995PubMedGoogle Scholar
  7. Billman GE, Hoskins RS (1989) Time-series analysis of heart rate variability during submaximal exercise. Evidence for reduced cardiac vagal tone in animals susceptible to ventricular fibrillation. Circulation 80: 146–157PubMedGoogle Scholar
  8. Billman GE, Hamlin RL (1996) The effects of a novel calcium channel antagonist, mibefradil, on refractory period and arrhythmias induced by programmed electrical stimulation and myocardial ischemia: a comparison with diltiazem and verapamil. J Pharmacol Exp Therap 277: 1517–1526Google Scholar
  9. Billman GE, Schwartz PJ, Stone HL (1982) Baroreceptor reflex control of heart rate: A predictor of sudden death. Circulation 66:874–880PubMedGoogle Scholar
  10. Billman GE, Schwartz PJ, Stone HL (1984) The effects of daily exercise on susceptibility to sudden cardiac death. Circulation 69: 1182–1189PubMedGoogle Scholar
  11. Billman GE, McIlroy B, Johnson JD (1991) Elevated myocardial calcium and its role in sudden cardiac death. FASEB J 5: 2586–2592PubMedGoogle Scholar
  12. Billman GE, Avendano CE, Halliwill JR, Burroughs JM (1993) The effects of the ATP-dependent potassium channel antagonist glyburide on coronary blood flow and susceptibility to ventricular fibrillation. J Cardiovasc Pharmacol 21:197–204PubMedGoogle Scholar
  13. Billman GE, Castillo LC, Hensley J, Hohl CM, Altschuld RA (1997) β2-adrenergic receptor antagonists protect against ventricular fibrillation: In vivo evidence and in vitro evidence for enhanced sensitivity to β2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96: 1914–1922PubMedGoogle Scholar
  14. Billman GE, Englert HC, Schoelkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel; Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Therap 286: 1465–1473Google Scholar
  15. Collins MN, Billman GE (1989) Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation. Am J Physiol Heart Circ Physiol 257:H1886–H1894Google Scholar
  16. Davis HT, Decamilla J, Bayer LW, Moss AJ (1979) Survivorship patterns in the post hospital phase of myocardial infarction. Circulation 64: 1252–1258Google Scholar
  17. Gögelein H (2001) Inhibition of cardiac ATP-dependent potassium channels by sulfonylurea drugs. Curr Opin Invest Drugs 2: 71–80Google Scholar
  18. Gögelein H, Hartung J, Englert HC, Scholkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells. J Pharmacol Exp Ther 286: 1453–1464PubMedGoogle Scholar
  19. Halliwill JR, Billman GE, Eckberg DL (1998) Effect of a vagomimetic atropine dose on canine cardiac vagal tone and susceptibility to sudden cardiac death. Clin Auton Res 8: 155–164CrossRefPubMedGoogle Scholar
  20. Houle MS, Billman GE (1999) Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol Heart Circ Physiol 267: H215–H223Google Scholar
  21. Lappi MD, Billman GE (1993) The effect of ryanodine on ventricular fibrillation induced by myocardial ischemia. Cardiovasc Res 27: 2152–2159PubMedGoogle Scholar
  22. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351: 478–484CrossRefPubMedGoogle Scholar
  23. Schuster EH, Bulkley BH (1980) Ischemia at a distant site after myocardial infarction: a cause of early postinfarction angina. Circulation 62: 509–515PubMedGoogle Scholar
  24. Schwartz PJ, Billman GE, Stone HL (1984) Autonomic mechanisms in VF due to acute myocardial ischemia during exercise in dogs with healed myocardial infarction: An experimental model for sudden cardiac death. Circulation 69: 790–800PubMedGoogle Scholar
  25. Schwartz PJ, Vanoli E, Stramba-Badiale M, DeFerrari GM, Billman GE, Foreman RD (1988) Autonomic mechanisms and sudden death, new insight from the analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78: 969–979PubMedGoogle Scholar
  26. Study Group on Experimental Arrhythmia Research of the Working Group on Arrhythmias of the European Society of Cardiology (1995) The role of basic arrhythmia research: the continued need for experiments in the intact heart and organism. Eur Heart J 16: 1469–1475Google Scholar
  27. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043–1065Google Scholar
  28. Trolese-Mongheal Y, Duchene-Marullaz P, Trolese J-F, Leinot M, Lamar J-C, Lacroix P (1985) Sudden death and experimental acute myocardial infarction. Am J Cardiol 56: 677–681CrossRefPubMedGoogle Scholar
  29. Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98: 2334–2351PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • George E. Billman
    • 1
  1. 1.Department of Physiology and Cell BiologyThe Ohio State UniversityColumbusUSA

Personalised recommendations